EGFR and neoplasm: While these findings contradict reports showing that mutant EGFR suppresses MHC I expression and is negatively correlated with MHC expression in advanced LUAD119, it is conceivable that during tumor initiation, there is a fine balance between an active immune response and a concomitant tumor-elicited immune suppression.